CDH1 and breast carcinoma: Elevation of N-cadherin expression, a known mesenchymal marker, with the concomitant decrease of E-cadherin contributes to the loss of adhesion between tumor cells [22]; which is observed more prominently among basal-like breast cancers as well as in HER2+ tumors [18].